600436.SS
600436.SS
CNE000001F21
ZHANGZHOU PIENTZEHUANG PHARMACE
Loading chart...

Company Profile

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals under the Pien Tze Huang brand name. It is also involved in the sale of food; production of skin, hair, and oral care daily products; biotechnology and medical device research and development; sale of medical machinery; and online wholesale and retail. The company's products are used for liver diseases, cardiovascular and cerebrovascular, cancer, cold, dermatology, and other applications. It exports its products. The company was founded in 1956 and is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Related stocks

002422.SZ
002422.SZ • China
KELUN PHARMA
39.72 CNY
9.45B USD 1Y +10.1%
1093.HK
1093.HK • China
CSPC PHARMA
9.09 HKD
13.2B USD 1Y -3.4%
4528.T
4528.T • Japan
ONO PHARMACEUTICAL CO
2,259 JPY
6.71B USD 1Y +22%
4568.T
4568.T • Japan
DAIICHI SANKYO COMPANY LIMITED
2,623 JPY
30.16B USD 1Y -37.2%
4503.T
4503.T • Japan
ASTELLAS PHARMA
2,247.5 JPY
25.47B USD 1Y +35.2%
002019.SZ
002019.SZ • China
YIFAN PHARM
9.66 CNY
1.76B USD 1Y -30.7%
GLAXO.NS
GLAXO.NS • India
GLAXOSMITHKLINE PHARMA LT
2,540.3 INR
4.45B USD 1Y -8%
4536.T
4536.T • Japan
SANTEN PHARMACEUTICAL CO
1,684 JPY
3.42B USD 1Y +7.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.6% p.a.
Max Drawdown (5Y)
-77.5%
Sharpe Ratio (5Y)
-0.83
Beta Factor
0.26
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -78.0% in the extended horizon.
ende